Sari Reisner, ScD, Named WPATH Board Member-At-Large

We are pleased to announce that Sari Reisner, ScD, Affiliated Investigator at The Fenway Institute and Director of Transgender Health Research, has been named a World Professional Association for Transgender Health (WPATH) Board Member-at-Large. His four-year term begins on September 20, 2022, when Dr. Reisner and his fellow new board members will be installed at the 27th Scientific Symposium, being held in Montreal, Quebec, Canada.

WPATH is a 501(c)(3) non-profit, interdisciplinary professional and educational organization devoted to transgender health. Its professional, supporting, and student members engage in clinical and academic research to develop evidence-based medicine and strive to promote a high quality of care for transsexual, transgender, and gender-nonconforming individuals internationally. The mission of WPATH is to promote evidence based care, education, research, public policy, and respect in transgender health.

Dr. Reisner is also Director of Transgender Research and Assistant Professor in the Department of Medicine at Harvard Medical School, based in the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital, and Assistant Professor in the Department of Epidemiology at Harvard T.H. Chan School of Public Health. He has co-authored more than 150 peer-reviewed journal articles and was honored as a member of the 2015 Trans100 List—celebrating work “by” and “for” transgender people—in recognition of his contributions in transgender health.

Trained as a social and psychiatric epidemiologist, Dr. Reisner’s research focuses on: (1) health disparities and inequities in lesbian, gay, bisexual, transgender, queer/ questioning (LGBTQ) populations, with specialization in local, national, and global transgender and gender nonconforming health; (2) the epidemiology of infectious diseases including HIV and sexually transmitted infections (STIs) in marginalized, underserved populations, with focus in biobehavioral intervention design and development; (3) psychiatric epidemiology concentrating on mental health and substance use/abuse risks and resiliencies in adolescents and young adults.

Please join us on congratulating Dr. Reisner on this well-earned appointment!


Subscribe to our Newsletter

Want to receive email updates about what’s happening at Fenway Health? 

Share this post with your friends

Translate »